Abeona Therapeutics Inc.
ABEO
$5.29
$0.428.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -47.39% | -34.44% | 37.94% | 21.89% | 24.56% |
| Gross Profit | 47.39% | 38.78% | -37.94% | -21.89% | -24.56% |
| SG&A Expenses | 201.59% | 98.35% | 37.39% | 31.70% | 54.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.52% | 29.83% | 37.66% | 26.22% | 35.39% |
| Operating Income | -56.52% | -27.59% | -37.66% | -26.22% | -35.39% |
| Income Before Tax | 32.74% | 1,578.98% | 61.91% | 43.99% | -155.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 82.95% | 1,369.52% | 61.91% | 43.99% | -155.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.95% | 1,369.52% | 61.91% | 43.99% | -155.74% |
| EBIT | -56.52% | -27.59% | -37.66% | -26.22% | -35.39% |
| EBITDA | -57.56% | -28.03% | -38.69% | -26.85% | -37.41% |
| EPS Basic | 84.89% | 1,019.39% | 79.10% | 70.44% | -31.89% |
| Normalized Basic EPS | 40.38% | -388.16% | 79.10% | 70.35% | -31.91% |
| EPS Diluted | 84.13% | 749.79% | 79.10% | 70.44% | -31.99% |
| Normalized Diluted EPS | 40.38% | -390.71% | 79.10% | 70.35% | -31.91% |
| Average Basic Shares Outstanding | 12.81% | 31.28% | 82.24% | 89.46% | 93.90% |
| Average Diluted Shares Outstanding | 12.81% | 30.09% | 82.24% | 89.46% | 93.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |